Discover 1,609 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,609
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
for
Peripheral Arterial Disease
Location: Raleigh NC, Chapel Hill NC, Richmond VA, Akron OH,
Sponsor: Juventas Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT02544204
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
for
Breast Cancer
Location: Raleigh NC, Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT03769415
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
for
Benign Prostatic Hyperplasia
Location: Raleigh NC, New York NY, Syosset NY, Daytona Beach FL,
Sponsor: Rivermark Medical
Sex: Male
Age: 45+
Code: NCT06849258
Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Chapel Hill NC, Fairfax VA, Washington D.C. DC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase1, Phase2, Recruiting
Active & Responsive
Oxygen Toxicity: Mechanisms in Humans
for
Oxygen Toxicity, Hypercapnia, Seizures
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18 - 45
Code: NCT05761756
Recruiting
Featured
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: Chapel Hill NC, Winston-Salem NC, Charlotte NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04895436
Phase2, Recruiting
Featured
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Chapel Hill NC, Philadelphia PA, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT06332534
Phase3, Recruiting
Featured
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Chapel Hill NC, Roanoke VA, Fairfax VA, Atlanta GA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase2, Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Durham NC, Fairfax VA, New York NY, Nashville TN,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase2, Recruiting
ELEVATE-HFpEF Clinical Study
for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Durham NC, Charleston SC, Falls Church VA,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Sex: All
Age: 40+
Code: NCT06678841
Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Durham NC, Huntersville NC, Fairfax VA, Louisville KY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
Hydrus® Microstent New Enrollment Post-Approval Study